Stay updated on Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T02:27:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0 and v3.4.3 has been removed.
    Difference
    0.1%
    Check dated 2026-03-22T08:50:48.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Page revision indicator updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T20:20:30.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.4.1 to v3.4.2, which appears to be a backend/version label with no visible impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:58:49.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T22:52:18.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The updates add UI elements to show/hide the glossary and adjust the page's metadata in the footer, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing the previous labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-23T17:24:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hodgkin Lymphoma: Frontline Clinical Trial page.